BioAdaptives, Inc.
BDPT
$0.01
$0.00-14.06%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.20K | 7.80K | 3.20K | 700.00 | 12.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.20K | 7.80K | 3.20K | 700.00 | 12.70K |
| Cost of Revenue | 5.80K | 3.00K | 62.20K | 81.60K | 90.00K |
| Gross Profit | 12.60K | 5.00K | -58.90K | -80.90K | -77.30K |
| SG&A Expenses | 1.05M | 1.13M | 927.60K | 702.40K | 504.80K |
| Depreciation & Amortization | 4.00K | 2.50K | 1.00K | 0.00 | 1.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.06M | 1.14M | 990.70K | 784.00K | 596.70K |
| Operating Income | -1.04M | -1.13M | -987.50K | -783.30K | -584.00K |
| Income Before Tax | -1.56M | -1.11M | -764.40K | -789.50K | -899.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.56 | -1.11 | -0.76 | -0.79 | -0.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.56M | -1.11M | -764.40K | -789.50K | -899.10K |
| EBIT | -1.04M | -1.13M | -987.50K | -783.30K | -584.00K |
| EBITDA | -1.04M | -1.13M | -986.60K | -782.90K | -582.10K |
| EPS Basic | -0.14 | -0.11 | -0.08 | -0.13 | -0.14 |
| Normalized Basic EPS | -0.10 | -0.08 | -0.05 | -0.07 | -0.09 |
| EPS Diluted | -0.14 | -0.11 | -0.08 | -0.13 | -0.14 |
| Normalized Diluted EPS | -0.10 | -0.08 | -0.05 | -0.07 | -0.09 |
| Average Basic Shares Outstanding | 40.85M | 38.73M | 36.70M | 30.16M | 28.81M |
| Average Diluted Shares Outstanding | 40.85M | 38.73M | 36.70M | 30.16M | 28.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |